Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/1995
11/02/1995EP0679190A1 Method for generating single-stranded dna molecules
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0562047A4 Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
10/1995
10/31/1995US5463175 Glyphosate tolerant plants
10/31/1995US5462862 Antibiotics from microorganisms
10/31/1995US5462854 Amenable to enzymatic elongation from either, or most preferably both termini under appropriate conditions and in presence of polymerase enzyme
10/31/1995US5462748 For stepwise addition of biopolymer subunits to growing biopolymer chain on a solid phase support
10/28/1995CA2147798A1 Nucleosides and oligonucleotides having 2'-ether groups
10/26/1995WO1995028640A1 Complex combinatorial chemical libraries encoded with tags
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028412A1 α(1,3) GALACTOSYLTRANSFERASE NEGATIVE SWINE
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995CA2187802A1 .alpha.(1,3) galactosyltransferase negative swine
10/26/1995CA2187792A1 Complex combinatorial chemical libraries encoded with tags
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/25/1995EP0678578A2 Multiple drug resistance gene of Aureobasidium pullulans
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678096A1 Synthesis of dimmer blocks and their use in assembling oligonucleotides.
10/21/1995CA2147110A1 Multiple drug resistance gene of aureobasidium pullulans
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027721A1 Freeze-dried compositions comprising rna
10/19/1995WO1995027718A2 Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides
10/19/1995WO1995006764A3 Oligonucleotides with rna cleavage activity
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187338A1 Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677584A1 Stable mutants of D-N-alpha-carbamylase
10/18/1995EP0677115A1 Tia-1 binding proteins and isolated complementary dna encoding the same
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677057A1 Biopolymer synthesis utilizing surface activated, organic polymers
10/18/1995EP0677055A1 Antisense molecules directed against a fibroflast growth factor receptor gene family
10/18/1995EP0677053A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0629144B1 Device for simultaneously or successively carrying out chemical reactions
10/18/1995EP0291533B1 Rna ribozyme restriction endoribonucleases and methods
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110278A Oligonucleotide capable of inhibiting endothelin generation
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459037 Electrophoresis, change in RNA expression due to drugs, physiological or pathological conditions
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995US5459015 High-affinity RNA ligands of basic fibroblast growth factor
10/17/1995CA2011020C Compositions and protocols applicable to genetic analysis
10/17/1995CA1337336C Human papillomavirus nucleic acid hybridization probes and methods for employing the same
10/12/1995WO1995027072A1 Determination and identification of active compounds in a compound library
10/12/1995WO1995027066A2 Dna encoding ubiquitin conjugating enzymes
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027054A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995026982A2 Malaria peptides
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026972A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995WO1995026751A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026733A1 Oligonucleoside cleavage compounds and therapies
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995CA2186107A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995CA2185918A1 Determination and identification of active compounds in a compound library
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/11/1995EP0676472A1 Human manganese superoxide dismutase (hMn-SOD)
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0675969A1 Improved method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction.
10/11/1995EP0675968A1 Enzyme-catalyzed chemiluminescent detection of proteins and nucleic acids using hydroxyaryl cyclic diacylhydrazide compounds
10/11/1995EP0675965A1 Polynucleotide immobilized support
10/11/1995EP0675963A1 Method and apparatus for enzymatic synthesis of oligonucleotides
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0675953A1 Soluble peptides having constrained, secondary conformation in solution and method of making same
10/11/1995EP0675873A1 Synthesis of encoded polymers
1 ... 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 ... 899